Abstract submission is NOW OPEN through Jan. 31, 2025! Send us your research for possible presentation at the 28th Annual Meeting!
ASGCT's comprehensive review and selection process focuses and the quality and strength of each individual submission.
All abstracts are reviewed by a group of volunteer reviewers assigned to each category selected by the Secretary and Abstract Chair. Abstract reviewers consider several variables in rating the abstract for selection as an oral presentations. General considerations include the quality of the research and presentation, the strength of the results and methods, and whether the reported research significantly advances the field. The committees also reject any submissions that are clear advertisements of a product or service or show very little scientific merit.
For the Annual Meeting, each review committee is made up of 5-7 individuals from varying backgrounds who specialize in the category assigned. Upon review, they are able to put forward suggested abstracts for the Presidential Symposium and the Clinical Trials Symposium. These abstracts are then further reviewed by our Abstract Advisory Group, which is made up of the President, President-elect, Secretary, and a small group of reviewers of their choosing.
For our Annual Meeting, there will be a call for abstract reviewers in the fall in accordance with the abstract categories decided by the Abstract Advisory Group.
Our other events are reviewed by the Programming Committee, which is chosen by the President.
November 19-20, 2024 | Chicago, IL
© 2000-2024 All rights reserved. American Society of Gene & Cell Therapy.
Kentico CMS Development by Reason One | Powered by Kentico